IDEAYA Biosciences预计2026年底前公布IDE849全球一期临床试验初步数据

美股速递
Feb 17

IDEAYA Biosciences(股票代码:IDYA)宣布,由其主导的IDE849全球一期临床试验的初步临床数据更新,预计将在2026年底前发布。该试验旨在评估IDE849在患者中的安全性和有效性,为后续开发提供关键依据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10